956901-17-0

Basic information

• Product Name: 7-fluoroquinoline-6-carbonitrile
• Synonyms: 7-fluoro-6-quinolinecarbonitrile
• CAS NO: 956901-17-0
• Molecular Formula: C10H5FN2
• Molecular Weight: 172.16
• Mol File: 956901-17-0.mol
• Article Data: 5

Chemical Properties

• Appearance: /
• CAS DataBase Reference: 7-fluoroquinoline-6-carbonitrile(CAS DataBase Reference)
• NIST Chemistry Reference: 7-fluoroquinoline-6-carbonitrile(956901-17-0)
• EPA Substance Registry System: 7-fluoroquinoline-6-carbonitrile(956901-17-0)

Safety Data

• Hazardous Substances Data: 956901-17-0(Hazardous Substances Data)

Usage

General Description

7-fluoroquinoline-6-carbonitrile is a chemical compound with the molecular formula C10H5FN2. It is a derivative of quinoline, which is a heterocyclic aromatic compound. The addition of a fluoro (F) atom at the seventh position and a cyano (CN) group at the sixth position of the quinoline ring gives this compound its unique properties. It is commonly used as a building block in the synthesis of various pharmaceuticals, agrochemicals, and organic compounds. 7-fluoroquinoline-6-carbonitrile has important applications in the field of medicinal chemistry and drug discovery, making it a valuable intermediate in the synthesis of biologically active molecules. Additionally, its fluorinated and nitrile functional groups make it an important scaffold for the development of new chemical entities with potential therapeutic and biological activities.

Upstream product

• 127827-52-5 6-bromo-7-fluoroquinoline 
• 544-92-3 copper(I) cyanide 
• 367-24-8 4-bromo-2-fluoroaniline 
• 656-65-5 3-fluoro-4-bromophenylamine 

Relevant articles and documents

NOVEL 3,5-DISUBSTITUTED-3H-IMIDAZO[4,5-B]PYRIDINE AND 3,5- DISUBSTITUTED -3H-[1,2,3]TRIAZOLO[4,5-B] PYRIDINE COMPOUNDS AS MODULATORS OF C-MET PROTEIN, ETC

The present invention provides compounds useful as c-Met protein kinase modulators, methods of preparing them, pharmaceutical compositions containing them and methods of treatment, prevention and/or amelioration of c-Met kinase mediated disease or disorders with them.

NOVEL 3,5-DISUBSTITUTED-3H-IMIDAZO[4,5-B]PYRIDINE AND 3,5- DISUBSTITUTED -3H-[1,2,3]TRIAZOLO[4,5-B] PYRIDINE COMPOUNDS AS MODULATORS OF PROTEIN KINASES

The present invention provides, inter alia, compounds of formula I as protein kinase modulators, methods of preparing them, pharmaceutical compositions containing them and methods of treatment, prevention and/or amelioration of kinase mediated diseases or disorders with them.

TRIAZOLOPYRAZINE DERIVATIVES

The invention relates to compounds of the formula I or a pharmaceutically acceptable salt thereof, wherein R1, R2, R3 and R4 are as defined herein. The invention also relates to pharmaceutical compositions containing the compounds of formula I and to methods of treating hyperproliferative disorders in a mammal by administering the compounds of formula I.